Recent Publications:
  • "The combination of lithium and L-dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson's disease therapy." Brain Res.
  • "Pharmacological prolyl hydroxylase domain inhibition as a therapeutic target for Parkinson's disease." CNS Neurol Disord Drug Targets 13:1 120-5
  • "Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulin." Antioxid. Redox Signal. 22:2 121-134
More publications from the Andersen Lab...
Core Technologies:
Bioinformatics >
Chemistry & Mass Spec >
Genomics >
Morphology & Imaging >
Change text size: